title: Poly-(R)-3-hydroxybutyrates (PHB) are Atherogenic Components of Lipoprotein Lp(a).
abstract: The hypothesis is that poly-(R)-3-hydroxybutyrates (PHB), linear polymers of the ketone body, R-3-hydroxybutyrate (R-3HB), are atherogenic components of lipoprotein Lp(a). PHB are universal constituents of biological cells and are thus components of all foods. Medium chain-length PHB (<200 residues) (mPHB) are located in membranes and organelles, and short-chain PHB (<15 residues) are covalently attached to certain proteins (cPHB). PHB are highly insoluble in water, but soluble in lipids in which they exhibit a high intrinsic viscosity. They have a higher density than other cellular lipids and they are very adhesive, i.e. they engage in multiple noncovalent interactions with other molecules and salts via hydrogen, hydrophobic and coordinate bonds, thus producing insoluble deposits. Following digestive processes, PHB enter the circulation in chylomicrons and very low density lipoproteins (VLDL). The majority of the PHB (>70%) are absorbed by albumin, which transports them to the liver for disposal. When the amount of PHB in the diet exceed the capacity of albumin to safely remove them from the circulation, the excess PHB remain in the lipid core of LDL particles that become constituents of lipoprotein Lp(a), and contribute to the formation of arterial deposits. In summary, the presence of PHB – water-insoluble, dense, viscous, adhesive polymers – in the lipid cores of the LDL moieties of Lp(a) particles supports the hypothesis that PHB are atherogenic components of Lp(a).
authors.forename: Rosetta N
authors.initials: RN
authors.lastname: Reusch
mesh_terms: D000418:Albumins / Q000737:chemistry; D050197:Atherosclerosis / Q000188:drug therapy*; D001692:Biological Transport; D002914:Chylomicrons / Q000737:chemistry; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood* / Q000737:chemistry*; D007657:Ketone Bodies / Q000737:chemistry; D008055:Lipids / Q000737:chemistry; D017270:Lipoprotein(a) / Q000737:chemistry*; D008079:Lipoproteins, VLDL / Q000737:chemistry; D011091:Polyesters / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry; D000091402:Prohibitins; D012307:Risk Factors; D012995:Solubility; D014783:Viscosity; D000094122:Polyhydroxybutyrates
chemical_list: D000418:Albumins; D002914:Chylomicrons; D006885:Hydroxybutyrates; D007657:Ketone Bodies; D008055:Lipids; D017270:Lipoprotein(a); D008079:Lipoproteins, VLDL; D011091:Polyesters; D011108:Polymers; D000091402:Prohibitins; C000717328:PHB protein, human; C003182:poly-beta-hydroxybutyrate; D000094122:Polyhydroxybutyrates